Novartis AG - Total Debt To Ebitda

Novartis AG's Fiscal Year is From January To December.

The item "Total-Debt-To-Ebitda" stands at 1.33 as of 09/30/2025, the lowest value since 12/31/2023.

As of the end of Novartis AG's third quarter, the item "Total Debt To Ebitda" stands at 1.33. This represents a decrease of -3.10 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -14.27 percent compared to the value the year prior.
The 1 year change in percent is -14.27.
The 3 year change in percent is 50.99.

The Serie's long term average value is 1.35. It's latest available value, on 09/30/2025, is 1.44 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2022, to it's latest available value, on 09/30/2025, is +50.99%.
The Serie's change in percent from it's maximum value, on 03/31/2023, to it's latest available value, on 09/30/2025, is -21.76%.